By continuing to browse this website, you consent to our use of cookies, as well as to our Terms of Use and Privacy Policy which provide additional information about how we process your data. This website uses cookies to enhance your user experience. Please read our Cookies Policy for more information on how we use cookies, as well as instructions on how to disable cookies. You may disable cookies through your internet browser settings, however this may result in some parts of the website not working properly for you.


Mediktor: AI medical diagnosis app wants to improve global health outcomes

Spain · May 02, 2019· By Gareth Gardiner Jones

Mediktor co-founder and CEO Cristian Pascual at 4YFN 2019, in Barcelona

NLP-based triage and diagnosis tool has achieved a 91% accuracy rate in clinical trials and raised €3 million funding 

As the world's population ages, the cost of healthcare to both governments and individuals is rising. Spanish AI-based diagnosis and triage tool Mediktor analyzes symptoms and directs patients to subsequent services or solutions, with the ultimate aim of reducing demand on over-stretched health systems across the globe. 

Developed in collaboration with doctors, Mediktor bills itself as "the most advanced and accurate symptom checker on the market for triage and pre-diagnosis." Its potential to disrupt the health services market lies in removing traditional barriers to seeing a doctor such as distance, time constraints and cost. It also hopes to help end the practice of self-diagnosis by internet searches, which it says delivers a misdiagnosis in 70% of cases. Its consultations are for information purposes only, however, and not intended to replace diagnoses from professionals.

Created in 2011, the system uses natural language processing (NLP) and intuitive algorithms to identify patients' symptoms in real time. Machine learning enables it to improve its intuition with every patient interaction. Last December Mediktor, which is accessed via its app and website, won the 2018 NODE.Health award for Best In Class Clinical Studies. 

"We are the only symptom checker in the world today to be validated by clinical trials with real patients," Mediktor co-founder and CEO Cristian Pascual told CompassList at Barcelona's recent 4YFN 2019.

"We did a study with a major hospital in Barcelona, interacting with more than 1,000 emergency department patients. We compared the results from the machine with the diagnosis from the real hospital. The conclusion was that in 91.3% of the cases, the [doctor's diagnosis] appeared in the list of 10 possible conditions [offered by the machine]."

Mediktor's current expansion plans target the US and Europe, and it already has an office in New York. In September 2018, it raised €3 million in Series A funding for international scalability and further product development from French multinational NAOS, as well as from Dutch VC Castel Capital and local sciencetech Alta Life Sciences.  

Edited by Sophie Douez

This page is exclusive for Premium subscribers

Subscribe now to continue accessing our full range of insights and data.


Already have a Lister Premium Account? LOG IN